Cancer Targeted Technology

Release Summary

Cancer Targeted Technology presents data on its PET imaging agent, CTT1057, from a prostate cancer clinical trial, and its radiotherapeutic drug, CTT1403, at key scientific and business meetings.

Cancer Targeted Technology